The ORVAC trial: a phase IV, double-blind, randomised, placebo-controlled clinical trial of a third scheduled dose of Rotarix rotavirus vaccine in Australian Indigenous infants to improve protection against gastroenteritis: a statistical analysis pl (Q98724872)
Jump to navigation
Jump to search
scientific article published on 26 August 2020
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The ORVAC trial: a phase IV, double-blind, randomised, placebo-controlled clinical trial of a third scheduled dose of Rotarix rotavirus vaccine in Australian Indigenous infants to improve protection against gastroenteritis: a statistical analysis pl |
scientific article published on 26 August 2020 |
Statements
The ORVAC trial: a phase IV, double-blind, randomised, placebo-controlled clinical trial of a third scheduled dose of Rotarix rotavirus vaccine in Australian Indigenous infants to improve protection against gastroenteritis: a statistical analysis plan (English)
Todd Graves
Bianca Middleton
James Totterdell
Thomas L Snelling
26 August 2020